MONOCLONAL ANTIBODY THERAPY

Memorial Hospital of Texas County in Guymon Oklahoma is providing the following monoclonal antibody therapy: Bamlanivimab/Etesevimab, Regen-COV, and Sotrovimab, for high risk patients with mild to moderate COVID-19 infections. The treatments are not right for every individual who tests positive for COVID-19. Early research shows the therapy is most effective for those individuals with less severe symptoms who receive treatment early after symptoms first appear.

Due to limited supply, only those individuals at greatest risk of hospitalization will be eligible to receive the outpatient treatment. Referral for outpatient treatment is based upon specific criteria set by the Food and Drug Administration (FDA).

Receiving Treatment
Infusion therapy is provided through physician referral only, after it is determined that a patient is a good candidate for treatment.

Contact your primary care provider for testing and referral to Memorial Hospital of Texas County, in Guymon Oklahoma.